What I have: TFC · tirzepatide.
The figures are clear enough; the question is what they mean and what they do not.
I can supply the numbers if the specifics change the answer.
What can I legitimately conclude from this figure?
What I have: TFC · tirzepatide.
The figures are clear enough; the question is what they mean and what they do not.
I can supply the numbers if the specifics change the answer.
What can I legitimately conclude from this figure?
The relevant arithmetic is that gross mass equals peptide plus counter-ion plus water, and the certificate usually reports only the first indirectly.
Acetate salts are produced by a deliberate ion exchange after purification. The exchange costs a processing step and is the reason acetate-form material is more expensive.
| Component | Typical share | Counted in purity? | Counted in content? |
|---|---|---|---|
| Target peptide | 88–94 % | Yes, as main peak | Yes |
| Related impurities | 1–3 % | Yes, as other peaks | No |
| Counter-ion (TFA or acetate) | 2–8 % | No | No |
| Residual water | 2–6 % | No | No |
| Bulking agent, if present | 0–40 % | No | No |
Net peptide content — the fraction of gross mass that is the peptide itself — is the figure that folds water and counter-ion together and is what you should ask for if you ask for anything.
Trifluoroacetate effects in cell culture are documented and are the technical basis for salt exchange to acetate.
Nothing here is medical advice, and research-use compounds are not approved for human use.
Water plus counter-ion is why gross mass and peptide mass differ.
Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.
Shop standardsAnswering this needs the purification method, since a trifluoroacetic acid mobile phase leaves trifluoroacetate unless a deliberate exchange was performed.
Trifluoroacetate has documented biological effects at higher concentrations in cell culture, which is the technical reason acetate exchange exists rather than a marketing one.
In practice, a supplier who reports both water and counter-ion has given you everything needed to reconcile the vial, and on this site that is a very short list.
Absence of a counter-ion figure is an absent measurement rather than a low one.
Trifluoroacetate unless a deliberate exchange was done. Ask which.
Answer first: the counter-ion is part of the mass you paid for and none of the peptide you wanted, and it can run to several per cent or more.
Worked reconciliation: a 10 mg vial at four per cent water and eight per cent trifluoroacetate contains 10.0 × 0.88 = 8.8 mg of peptide, a twelve per cent shortfall against label with a perfectly clean purity figure.
Quantification differs by ion: trifluoroacetate by ion chromatography or by fluorine nuclear magnetic resonance, acetate by ion chromatography or by capillary electrophoresis. Neither shows up on a UV chromatogram.
Peptides from reverse-phase purification with trifluoroacetic acid mobile phases are isolated as trifluoroacetate salts, which is standard synthesis practice.
Ask for net peptide content. It folds water and counter-ion into one usable number.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.